Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 25;11(2):378-84.
doi: 10.5114/aoms.2014.46796. Epub 2015 Mar 18.

Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence

Affiliations

Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence

Bolesław Kuzaka et al. Arch Med Sci. .

Abstract

Introduction: Urinary bladder cancer patients who have undergone transurethral resection of bladder tumor (TURBT) are at risk of recurrence. This study aims to correlate the level of bone morphogenetic protein (BMP) expression with urothelial carcinoma invasiveness, TNM stage and time to recurrence after TURBT.

Material and methods: In 33 specimens of healthy transitional epithelium and 42 of urothelial carcinoma, BMP2, BMP4 and BMP7 expression was determined by real-time polymerase chain reaction. Patients who underwent TURBT were followed up for 1 year.

Results: BMP2 and BMP7 were downregulated in infiltrating urothelial carcinoma, the relative expression being 0.76 (p = 0.04) and 0.28 (p = 0.025) respectively, while BMP4 was downregulated in non-invasive tumors. High expression of BMP2 and BMP7 correlated with prolonged time to recurrence (log-rank: p = 0.01 and p = 0.03 respectively).

Conclusions: Low expression of BMP2 and BMP7 is associated with shorter time to recurrence. The BMP expression levels are not indicative of tumor stage.

Keywords: bone morphogenetic protein 2; bone morphogenetic protein 4; bone morphogenetic protein 7; urinary tract epithelium; urothelial carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The BMP2, BMP4 and BMP7 expression level relative to healthy transitional epithelium (TE). Comparison between healthy urothelial transitional tissue (n = 33, empty bars) and urothelial carcinoma samples (n = 42, black bars) (A), BMP2 (B), BMP4 (C) and BMP7 (D) relative expression level in healthy TE (n = 33, TE), non-invasive urothelial carcinoma (n = 24, niUC) and invasive urothelial carcinoma (n = 18, iUC) Significance of the difference is indicated as follows *p < 0.05; **p < 0.01; Error bars represent SEM.
Figure 2
Figure 2
BMP2 (A), BMP4 (B), BMP7 (C) expression at different TNM stages (pTa (n = 24), pT1–2 (n = 8), pT3–4 (n = 10)). Presented values are relative to mean of normal transitional epithelium Horizontal lines represent median. r – Spearman's rank correlation coefficient between gene expression and TNM stages; p – statistical significance.
Figure 3
Figure 3
Kaplan-Meier estimators for UC recurrence probability for all analyzed subjects (n = 24) (A), BMP2 (B), BMP4 (C), BMP7 (D) Kaplan-Meier estimators for UC recurrence probability respectively Dashed line – low BMP expression, solid line – medium/high BMP expression. Significance of the differences is indicated (logrank test). +Censored data.

References

    1. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996;10:1580–94. - PubMed
    1. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242:1528–34. - PubMed
    1. Urist MR, O'Connor BT, Burwell RG. Bone grafts, derivatives and substitutes. Oxford: Butterworth-Heinemann; 1994.
    1. Feeley BT, Krenek L, Liu N, et al. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone. 2006;38:154–66. - PubMed
    1. Pathi S, Rutenberg JB, Johnson RL, Vortkamp A. Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation. Dev Biol. 1999;209:239–53. - PubMed

LinkOut - more resources